Kindly submity your manuscript with a concise cover letter clearly mentioning the title, type of manuscript (e.g, Research article, Review articles, Brief Reports, Case study etc) and choice of journal to be submitted. You can also submit your valuable manuscript through our online submission system. (A minimum of three reviewer suggestion is required by the author, in case you do not want to provide the names of potential reviewer you can fill "xxx" in the required fields).
Article Preparation Guidelines
Authors are expected to attach an electronic covering letter completely mentioning the type of manuscript (e.g, Research article, Review articles, Brief Reports, Case study etc). Unless invited on a special case, authors cannot classify a particular manuscript as Editorials or Letters to the editor or concise communications.
Confirm that each individual named as an author meets the uniform requirements of the journal criteria for authorship (briefly mention the contribution of each author).
Please make sure that the article submitted for review/publication is not under consideration elsewhere simultaneously.
Clearly mention financial support or benefits if any from commercial sources for the work reported in the manuscript, or any other financial interests that any of the authors may have, which could create a potential conflict of interest or the appearance of a conflict of interest with regard to the work.
A clear title of the article along with complete details of the author/s (professional/institutional affiliation, educational qualifications and contact information) must be provided in the tile page.
Corresponding author should include address, telephone number, fax number, and e-mail address in the first page of the manuscript and authors must address any conflict of interest with others once the article is published.
Number all sheets in succession, including references, tables, and figure legends.
Title page is the page 1. On the first page, type the running head (short title for top of each page), title (which cannot include any acronyms), names of the authors and their academic degrees, grants or other financial supporters of the study, address for correspondence and reprint requests, and corresponding author's telephone and fax numbers and e-mail address.
Guidelines for Research Articles
Review articles are written based mostly on secondary data that is falling in line with the theme of the journal. They are brief, yet critical discussions on a specific aspect of the subject concerned. Reviews generally start with the statement of the problem with a brief abstract of 300 words and few key words. Introduction generally brings the issue forward to the readers followed by analytical discussion with the help of necessary tables, graphs, pictures and illustrations wherever necessary. It summarizes the topic with a conclusion. All the statements or observations in the review articles must be based on necessary citations, providing complete reference at the end of the article.
Commentaries are opinion articles written mostly by the veteran and experienced writers on a specific development, recent innovation or research findings that fall in line with the theme of the journal. They are very brief articles with the title and abstract that provides the gist of the topic to be discussed, with few key words. It straight away states the problems and provides a thorough analysis with the help of the illustrations, graphs and tables if necessary. It summarizes the topic with a brief conclusion, citing the references at the end.
Case studies are accepted with a view to add additional information related to the investigative research that advances in the field of Pharmaceutics and Pharmacology and related fields.
It should add value to the main content/article submitted, by providing key insights about the core area. Cases reports must be brief and follow a clear format such as Cases and Methods Section (That describe the nature of the clinical issue and the methodology adopt to address it), discussion section that analyzes the case and a Conclusion section that sums up the entire case.
Editorials are concise commentaries on a currently published article/issue on Pharmaceutics, Pharmacology and other related branches of pharmacy. Editorial office may approach for any such works and authors must submit it within three weeks from the date of receiving invitation.
Letters to the Editor/Concise Communications
Letters to the editor should be limited to commentaries on previous articles published with specific reference to issues and causes related to it. It should be concise, comprehensive and brief reports of cases or research findings. It does not follow a format such as abstract, subheads, or acknowledgments. It is more a response or the opinion of the reader on a particular article published and should reach the editor within 6 months of article publication.
This section includes acknowledgment of people, grant details, funds, etc.
Conflict of Interest
The authors should declare conflict of interest (if any).
Note: If an author fails to submit his/her work as per the above instructions, they are requested to maintain clear titles namely headings, subheading.
The references should be cited in the text in large brackets e.g.  not in superscript or subscript. A complete reference should comprise the following:
An article in a journal
Author's Surname Initials (list only first three authors, if more than three authors are there use et al. after the third author). Title. Journal Year; Volume: Page no.
Olokoba AB, Obateru OA, Olokoba LB. Type 2 diabetes mellitus: a review of current trends. Oman Med J 2012; 4: 269-273.
Author's Surname Initials (list only first three authors, if more than three authors are there use et al. after the third author). Title. Publisher, Place of publication, Year of publication, Edition, Page no.
Rao CN, Muller A,Cheetham AK. The Chemistry on Nanomaterials. Synthesis, Properties and Applications,Wiley-Vch,Weinheim, 2004, 1, 115.
Author's Surname Initials (list only first three authors, if more than three authors are there use et al. after the third author) In: Editor’s Surname Editor’s Initials (Ed.), Book Title, Edition (if it is not the first edition) (Publisher, Place of publication, Year of publication) Pagenumber.
Clenshaw CK, Lord K, In: Scaife BKP (Ed.), Studies in Numerical Analysis (Academic Press, London and NewYork, 1974) 95.
A conference proceeding
Author's Surname Initials (list only first three authors, if more than three authors are there use et al. after the third author), In: Editor’s Surname Editor’s Initials (Ed.), Conference, date, place (town and country) of conference (Publisher, place of publication, year of publication) Page number.
Malarz KK, Kulakowski K, In: Simos TE (Ed.), International Conference of Computational Methods in Science and Engineering, 12-16 Sep. 2003, Kastoria, Greece (World Scientific, Singapore 2003) 258.
Author's Surname Initials, DSc/PhD/MSc/BSc thesis, University (town, country, year of publication).
Agutter AJ, PhD thesis, Edinburgh University (Edinburgh, UK, 1995).
An article in a newspaper
Author's Surname Initials (list only first three authors, if more than three authors are there use et al. after the third author), Newspaper Title, date of publication, Page number.
A. Sherwin, The Times, 13Jul.2007, 1.
Patents: A. B. Inventor, C. D. Inventor, (Holder), Country Code and patent number (registration year).
Submission check list:
Two Potential referees (if any).
Article Processing Charge (APC)
If the paper is accepted for publication, author will be asked to pay an Article Publication Fee to cover publications costs. There is no cost for submission of the article. The article processing charge is asked only after the acceptance of the article.
Article Processing Charges (APC)
Journal of Proteins & Peptides
Journal of Proteins & Peptides have discount/waiver policy for young researchers belonging from lower income countries as defined by World Bank. The waiver will be provided based on the quality of research and financial situation of the authors. Edwiser believes that money should not be a hindrance for bringing up quality scientific material to the society and we will do our best to encourage research in the middle and lower income countries.